Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We are pleased to confirm that once again we have replaced what we mined last year. We also saw an upgrade of about 69,000 ounces from inferred to measured and indicated. And our measured and indicated resources now amount to 4 million tons at a grade of 11.2 grams per ton for a total of 1.43 million ounces. Our inferred resources amounted to 3.7 million tons at a grade of 10.3 grams per ton for a total of 1.2 million ounces. And we also reported an update of our 2P reserves last night, which amounted to 2.2 million tons at a grade of 9 grams per ton for a total of 633,000 ounces.
So 2.4 million oz that is 10 years. And they will drill much much more in 2021. it is not reserves but resources have always translated into resources at Segovia in past, should continue.
The market value of our holdings of common shares and listed warrants in Aris currently totals about CAD150 million. $263usd million mkt cap - $120usd million Aris = $143 million mkt cap for Gran's business which has $188 million adj EBITDA , so its selling for less than 1 years of adj EBITDA, and less than 2X FCF, but it has $70 million more cash than debt so it is getting close to being for free.
Today CC, audio and text
https://seekingalpha.com/article/4417230-gran-colombia-gold-corp-tprff-ceo-lombardo-paredes-on-q4-2020-results-earnings-call
TPRFF is about 2 time free cash flow, a steal, have biggest position ever now.
after the 10K a steal, they are printing money.
T, 3rdLung so goodSuprised me,L&W is indeed Covid, as dive boats buy a lot of compressors and are crowded and their biz went way down like restaurants did, but it will come back. New CEO has told me he expects L&W to become a major rev source in future.
ThirdLung $529.6Kvs$310.8K or 70%Growth,Amazing
Just looking thru #s more they have done a great job growing their core biz.
Derek, agree Covid really hurt them 1st half, and hurt L&W for full year. So there should be big pent up demand.
Nemo sailed thru Covid because new product with huge demand, that even though hurt by Covid still grew like a weed. Imagine Nemo demand after Covid dies down this spring and summer.
Thanks Mat23, impressive sales growth
Amazing volume and price. Even though Nemo is driving this the rest of company should do very well. Exciting
Well Clogger, this is quite the market interest in BWMG. You are a gazillionaire.
This is big news for TPRFF and ALLXF which TPRFF is biggest owner of. Their ARIS stock may end up be worth more than TPRFF stock is today, the rest of TPRFF for free, the deposit can end up being huge at Marmoto. It is still up at depth and they found 2 new zones laterally. Have loaded up heavy in this price drop, have a ton of it.
Aris Gold announces drill results at the Marmato Deep Zone, including 78.1 metres at 3.43 g/t Au (true width 30.8 m)
PR NEWSWIRE 4:00 AM ET 3/9/2021
Symbol Last Price Change
ALLXF 1.8631up +0.1731 (+10.242604%)
QUOTES AS OF 03:59:59 PM ET 03/09/2021
VANCOUVER, BC , March 9, 2021 /PRNewswire/ - Aris Gold Corporation(ALLXF) (Aris Gold(ALLXF) or the Company) announces high-grade gold intercepts over broad widths at the Marmato mine in Colombia.
The 2020-2021 drill program that began in May 2020 at Marmato comprises 60 holes totalling 35,000 metres and is now approximately 50% complete. Drilling to date has demonstrated high-grade mineralization over broad widths, demonstrating potential to extend the 13-year mine life outlined in the Company's Pre-Feasibility Study dated September 18, 2020 with an effective date of March 17, 2020.
The principal objective of the drill campaign is to convert Inferred Mineral Resources to Indicated Mineral Resources. In addition to the Deep Zone, the campaign is also testing the newly discovered Fortaleza Zones A and B to the north, which opens up a new area that will require further drilling to evaluate its potential.
Aris Gold (ALLXF) CEO Neil Woodyer commented, "Our ongoing drill program at Marmato continues to deliver on our objective of adding to the already large gold inventory and 13-year mine life. Drilling in the Deep Zone is demonstrating potential for a larger, higher-grade system than previously envisioned. In addition, drilling on the newly discovered Fortaleza zones to the north confirms a prospective new area worthy of additional testing." https://www.arisgold.com/news/news-details/2021/Aris-Gold-announces-drill-results-at-the-Marmato-Deep-Zone-including-78.1-metres-at-3.43-gt-Au-true-width-30.8-m/default.aspx
There is a Seeking Alpha article on Atico
Atico Stock Will Not Ignore The Copper Price And Coming Q4 Much Longer
https://seekingalpha.com/instablog/535947-darp-research/5553739-atico-stock-will-not-ignore-copper-price-and-coming-q4-much-longer
Summary
The market has been ignoring that the Q4 will be spectacular for growth and profits due to shipment timing and copper price.
Atico is a deep value copper/gold miner with one of the lowest copper AISCs there is on their VMS style deposit El Roble mine.
The future La Plata Mine is much richer and has Gold, Copper, Zinc, Silver and Lead. The AISC for Copper will be negative due to other credits.
---more
Yes T, think it is the cheapest copper miner there is out there. have a bunch.
New high,broke double top at .058. In modern ear (last 5 years) that is all time high, a breakout
doubled in aftmrkt?
Amazing action. AnyNewsOrRumors?
Karora One of the best.NewCRUXvideo out o
https://www.cruxinvestor.com/videos/karora-resources-krr---gold-everywhere-they-look
https://apnews.com/press-release/accesswire/business-technology-products-and-services-new-products-and-services-automobile-parts-manufacturing-59cc2c69e90b6f78b3fc3ee8c2fae714
Their 2021 Q1 is same as calendar Q4 the above it it. Tomorrow 8am EST is ConfCall. The sales are up Y/Y a lot (200%) but this is down from Q4. There is a seasonal factor plus first sales from Raymond started Jan 2021 so not in this. They end with:
Positive Financial Outlook:
Additional sales personnel added to our direct sales team and growing momentum through OEM sales network.
UL2580 listing provides safety validation and unique competitive advantage.
Well positioned with working capital for growth from recent equity issues and strengthened balance sheet.
Company reiterates previously issued guidance.
Electrovaya is experiencing strong and growing customer demand for its battery products through both of its key sales channels: direct sales to end customers and OEM distribution.
The Company has added direct sales staff in the United States to bolster its direct sales channel and address the lead acid replacement market. The Company also anticipates growing demand from its OEM sales channel especially with the recent Raymond Strategic Supply Agreement. Raymond Corp is now extensively marketing and promoting Raymond’s lithium ion batteries through the firm’s sales network.
The Company continues to have a positive outlook for 2021. Although the year has started with some sales delays as described above, management anticipates meeting its previously released guidance. See “Forward-Looking Statements”.
Their guidance was high growth and they are still sticking with that.
thanks
$LXXGF Up22% New 3year high on CovidTestNews
Now we are up big, with a 1.22 high up 22% today. That is 3 year new highs, near all time highs blue sky breakout of 1.29
This is an easy stock for people to relate to and understand. It can become a popular stock both with pros and public alike.
Imagine what happens when FDA approves it.
LexaGene’s MiQLab is designed for point-of-care use and for simultaneous screening of numerous respiratory pathogens, including COVID-19 strain identification. The system is open-access, which allows for new tests to be easily loaded onto the system. This is a unique feature that is not found in any other system designed for point-of-care use.
Dr. Jack Regan, LexaGene’s CEO and Founder states, “Just three weeks ago, we designed assays to detect the UK and SA variants to demonstrate proof-of-principle that these assays could be quickly ported onto the MiQLab. ”
Broke prior high of $1.09, without a gap in the chart, that makes it a followthru breakout on prior 3 year Cup and Handle breakout. So we are at 3 year new high. https://www.globenewswire.com/news-release/2021/02/10/2173214/0/en/LexaGene-s-MiQLab-Successfully-Detects-Mutant-UK-and-South-African-COVID-19-Sequences.html
Now we are up big, with 1.22 high up 22%. That is 3 year new highs, near all time highs blue sky breakout of 1.29
This is an easy stock for people to relate to and understand. It can become a popular stock both with pros and public alike.
Imagine what happens when FDA approves it.
LexaGene’s MiQLab is designed for point-of-care use and for simultaneous screening of numerous respiratory pathogens, including COVID-19 strain identification. The system is open-access, which allows for new tests to be easily loaded onto the system. This is a unique feature that is not found in any other system designed for point-of-care use.
Dr. Jack Regan, LexaGene’s CEO and Founder states, “Just three weeks ago, we designed assays to detect the UK and SA variants to demonstrate proof-of-principle that these assays could be quickly ported onto the MiQLab. ”
Broke prior high of $1.09, without a gap in the chart, that makes it a followthru breakout on prior 3 year Cup and Handle breakout. So we are at 3 year new high. https://www.globenewswire.com/news-release/2021/02/10/2173214/0/en/LexaGene-s-MiQLab-Successfully-Detects-Mutant-UK-and-South-African-COVID-19-Sequences.html
Posting the Seeking Alpha article again
Is LexaGene The Perfect Stock?
https://seekingalpha.com/instablog/535947-darp-research/5551692-is-lexagene-perfect-stock?v=1612896879
Summary
LexaGene has just started sales of a revolutionary automated PCR machine that can test for 27 pathogens at once in about one hour.
It parallels Electrovaya, which have a recent 15 bagger on, a value nanocap stock in a highly favored sector that is likely to go profitable and have extreme growth.
I can find nothing wrong with the company as the management, market, technology and execution are all excellent.
Timing is perfect, they have just started sales with a $billion+ sales potential product and FDA approval to enter the POC market is possible in May.
LXXGF now +8% .97 very methodical buying, someone/s trying to buy without driving it up too fast . Already 670,000 shares. Intraday chart shows steady accumulation.
My prior post gives motive as to why it is getting bot.
$LXXGF BioPub video starting at 1hr 55m the issue is raised of LexaGene being bought out, licensed and uplisted, Jack covers that quickly in about 3 minutes then goes into a comparison with GenMark's products. Both have automated PCR testing equipment. This part of video is especially valuable.
$LXXGF BioPub video starting at 1hr 55m the issue is raised of LexaGene being bought out, licensed and uplisted, Jack covers that quickly in about 3 minutes then goes into a comparison with GenMark's products. This part of video is especially valuable.
$LXXGF 2019 Forbes article on LexaGene, wow!
This New Device’s Rapid Pathogen Identification May Be Our Next Big Medical Breakthrough
https://www.forbes.com/sites/jimvinoski/2019/12/10/this-new-devices-rapid-pathogen-identification-may-be-our-next-big-medical-breakthrough/?sh=7bbd35252f63
What if we had a piece of technology that could quickly detect and identify those nasty little creatures that cause so much heartache, illness and death, allowing fast diagnoses for illness prevention and treatment? LexaGene, a start-up in Beverly, Massachusetts, may have just that.
This was Dec 2019, now LexaGene is to market. And look at pic, they have made MiQLab smaller.
How rare that is, a nanocap geting covered by Forbes.
New artcile on it on Seeking Alpha: Is LexaGene The Perfect Stock?
Conclusion
The PCR medical testing sector is a wonderful business with very high stock market valuations and buyout valuations. It is recession resistant, in fact the best year ever for PCR was the recession of 2020. LexaGene's MiQLab is a breakthrough product in terms of cost, ease of use, and open access. Am expecting that the FDA will approve it in 2021 for human POC and that LexaGene will be able to generate multiple millions in revenue within a year. Believe that will result in a 10 bagger or better, which would be $8 a share. Can find nothing wrong with this company after studying it for a week. So the answer the question in the title, yes LexaGene is the perfect stock.
https://seekingalpha.com/instablog/535947-darp-research/5551692-is-lexagene-perfect-stock
$LXXGF 2019 Forbes article on LexaGene, wow!
This New Device’s Rapid Pathogen Identification May Be Our Next Big Medical Breakthrough
https://www.forbes.com/sites/jimvinoski/2019/12/10/this-new-devices-rapid-pathogen-identification-may-be-our-next-big-medical-breakthrough/?sh=7bbd35252f63
What if we had a piece of technology that could quickly detect and identify those nasty little creatures that cause so much heartache, illness and death, allowing fast diagnoses for illness prevention and treatment? LexaGene, a start-up in Beverly, Massachusetts, may have just that.
This was Dec 2019, now LexaGene is to market. And look at pic, they have made MiQLab smaller.
How rare that is, a nanocap geting covered by Forbes.
New artcile on it on Seeking Alpha: Is LexaGene The Perfect Stock?
Conclusion
The PCR medical testing sector is a wonderful business with very high stock market valuations and buyout valuations. It is recession resistant, in fact the best year ever for PCR was the recession of 2020. LexaGene's MiQLab is a breakthrough product in terms of cost, ease of use, and open access. Am expecting that the FDA will approve it in 2021 for human POC and that LexaGene will be able to generate multiple millions in revenue within a year. Believe that will result in a 10 bagger or better, which would be $8 a share. Can find nothing wrong with this company after studying it for a week. So the answer the question in the title, yes LexaGene is the perfect stock.
https://seekingalpha.com/instablog/535947-darp-research/5551692-is-lexagene-perfect-stock
Forbes had LexaGen Article a year ago befor Covid. It talks about how good for fighting pandemics LexaGene's system is.
Just found 2019 Forbes article on LexaGen, wow This New Device’s Rapid Pathogen Identification May Be Our Next Big Medical Breakthrough
https://www.forbes.com/sites/jimvinoski/2019/12/10/this-new-devices-rapid-pathogen-identification-may-be-our-next-big-medical-breakthrough/?sh=7bbd35252f63
What if we had a piece of technology that could quickly detect and identify those nasty little creatures that cause so much heartache, illness and death, allowing fast diagnoses for illness prevention and treatment? LexaGene, a start-up in Beverly, Massachusetts, may have just that.
This was Dec 2019, now LexaGene is to market. And look at pic, they have made MiQLab smaller.
$LXXGF New Article on SeekingAlpha CallsFor 10Bagger
https://seekingalpha.com/instablog/535947-darp-research/5551692-is-lexagene-perfect-stock
Is LexaGene The Perfect Stock?
Feb. 5, 2021 11:54 AM ET|9 comments |About: Electrovaya Inc. (EFLVF), GNMK, LXXGF, Includes: BGNE
Summary
LexaGene has just started sales of a revolutionary automated PCR machine that can test for 27 pathogens at once in about one hour.
It parallels Electrovaya, which have a recent 15 bagger on, a value nanocap stock in a highly favored sector that is likely to go profitable and have extreme growth.
I can find nothing wrong with the company as the management, market, technology and execution are all excellent.
Timing is perfect, they have just started sales with a $billion+ sales potential product and FDA approval to enter the POC market is possible in May.
New Article on LexaGene on SeekingAlpha CallsFor10Bagger
https://seekingalpha.com/instablog/535947-darp-research/5551692-is-lexagene-perfect-stock
Is LexaGene The Perfect Stock?
Feb. 5, 2021 11:54 AM ET|9 comments |About: Electrovaya Inc. (EFLVF), GNMK, LXXGF, Includes: BGNE
Summary
LexaGene has just started sales of a revolutionary automated PCR machine that can test for 27 pathogens at once in about one hour.
It parallels Electrovaya, which have a recent 15 bagger on, a value nanocap stock in a highly favored sector that is likely to go profitable and have extreme growth.
I can find nothing wrong with the company as the management, market, technology and execution are all excellent.
Timing is perfect, they have just started sales with a $billion+ sales potential product and FDA approval to enter the POC market is possible in May.
Anyone buy on article?, it is up 47%
$ENSV ShortSqueezeArticleGains47% in 6Days,BeatsGME 6to1
Why Enservco Is A Better Short Squeeze Than GameStop
Update 2-4-2021: Why Enservco Is A Better Short Squeeze Than GameStop: Consider this article a great success in just 6 days. Yesterday in aftermarket it hit 2.75. Today premarket do not know the high but at was at least $3.05, this article was written at 2.08 so a 47% gain in 6 days on this article. The after and pre market activity was high volume with tight spreads, similar to normal hours.
I am mostly holding but did sell down 10-15% or so with short squeeze "catcher" orders. Highest in AM premarket was a 3.05 sell. BTW did buy back after the open at 2.37-2.42, it is a dream stock for short squeezing- -- To illustrate how huge a outperform ENSV has been, $10,000 in GME has become $2,400, and $10,000 in ENSV at my sell at $3.05 in pre market became $14,700. That is 6.37 Times more than a GME trade, and GME is only a trade. Whereas ENSV is a good value investment with short squeeze turbo charging. Hence this article's title: https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
Hope someone was able to benefit from this, and it is still live. The opportunity still there as this value stock yoyos up and down extremely.
$ENSV ShortSqueezeArticleGains47% in 6Days,BeatsGME 6to1
Why Enservco Is A Better Short Squeeze Than GameStop
Update 2-4-2021: Why Enservco Is A Better Short Squeeze Than GameStop: Consider this article a great success in just 6 days. Yesterday in aftermarket it hit 2.75. Today premarket do not know the high but at was at least $3.05, this article was written at 2.08 so a 47% gain in 6 days on this article. The after and pre market activity was high volume with tight spreads, similar to normal hours.
I am mostly holding but did sell down 10-15% or so with short squeeze "catcher" orders. Highest in AM premarket was a 3.05 sell. BTW did buy back after the open at 2.37-2.42, it is a dream stock for short squeezing- -- To illustrate how huge a outperform ENSV has been, $10,000 in GME has become $2,400, and $10,000 in ENSV at my sell at $3.05 in pre market became $14,700. That is 6.37 Times more than a GME trade, and GME is only a trade. Whereas ENSV is a good value investment with short squeeze turbo charging. Hence this article's title: https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
$ENSV ShortSqueezeArticleGains47% in 6Days,BeatsGME 6to1
Why Enservco Is A Better Short Squeeze Than GameStop
Update 2-4-2021: Why Enservco Is A Better Short Squeeze Than GameStop: Consider this article a great success in just 6 days. Yesterday in aftermarket it hit 2.75. Today premarket do not know the high but at was at least $3.05, this article was written at 2.08 so a 47% gain in 6 days on this article. The after and pre market activity was high volume with tight spreads, similar to normal hours.
I am mostly holding but did sell down 10-15% or so with short squeeze "catcher" orders. Highest in AM premarket was a 3.05 sell. BTW did buy back after the open at 2.37-2.42, it is a dream stock for short squeezing- -- To illustrate how huge a outperform ENSV has been, $10,000 in GME has become $2,400, and $10,000 in ENSV at my sell at $3.05 in pre market became $14,700. That is 6.37 Times more than a GME trade, and GME is only a trade. Whereas ENSV is a good value investment with short squeeze turbo charging. Hence this article's title: https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
I posted this 6 days ago, anyone get any ENSV and profit?
Green*13 love it, Stewart is great at this type of stuff. Thanks
Thanks Green*13,CrammerConfession, will save that video. Eye opening. Any time someone claims manipulation does not exist, will show then that video.
Only two stocks that have traded 3TimesTotalStockIn1day.
About 10 days ago GME did it 3 days in a row. I think due to naked shorting, hard to explain 3 times more volume than stock in a day, some stocks do not do it in a year.
About 3 years ago SAEX did it. But in last year only know of two. Thursday ENSV did it. There is a Seeking Alpha article about that.
https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
Naked shorting is getting dangerous.
Chris,did you see Yahoo interview of CEO? He would not give real answers even after host chided him on not answering questions.
$ENSV squeezed on 3TimesMoreStockVolume than all the stock.
Thursday 14 million trades, but there are only 5 million shares. It is a real company 39 years old and normally profitable. Oil services.
There is Seeking Alpha article3 on the short situation.
https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
Why Enservco Is A Better Short Squeeze Than GameStop
Conclusion:
On a value basis Enservco (ENSV) is worth more than the $10 million market cap it has. It has been around for 39 years and has been down to the $2-4 range 9 times in those 39 years. It has also been to $40 seven times is those 40 years, and once to $117, which is a 60 bagger a rarity for any stock. Going to $5 or $10 in an oil upcycle is totally reasonable, ignoring the short squeeze potential, as it has so frequently cycled between "in favor" and "out of favor". It it is a real company with a CEO who is on side of investors as he is the biggest investor in it.
However there is another factor, the volume on Tuesday and prior short squeezes of Enservco, its very expensive short interest rate to lend, being there are only about 15,000 shares left to short and the indications it is heavily naked shorted indicate it is very vulnerable to a huge short squeeze. Who has been squeezing it? Have no idea. But if the investors in ENSV only sell 10-20% on the days the stock is up 25-50% on a squeeze it would seem a super squeeze would take place and it could reach its $5-10 target in days or even hours.
Anyone here know stock WithTripleVolumeOfAllStockIn1Day? Like $ENSV?
It appears heavily naked shorted like GME. I am interested in any stock that trades 3 time more in one day that all the stocks. Please post if you know one.
here is short data on ENSV
https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop?v=1611976600
Why Enservco Is A Better Short Squeeze Than GameStop
$ENSV went up 39% on 200%>VolumeThanStockExists, NakedShort?
ShortData indicates $ENSV heavily naked shorted,SeekingAlphaArticle
has new data on that: https://seekingalpha.com/instablog/535947-darp-research/5548999-why-enservco-is-better-short-squeeze-gamestop
Why Enservco Is A Better Short Squeeze Than GameStop
The company is 39 years old. here is snip on that:
Conclusion:
On a value basis Enservco (ENSV) is worth more than the $10 million market cap it has. It has been around for 39 years and has been down to the $2-4 range 9 times in those 39 years. It has also been to $40 seven times is those 40 years, and once to $117, which is a 60 bagger a rarity for any stock. Going to $5 or $10 in an oil upcycle is totally reasonable, ignoring the short squeeze potential, as it has so frequently cycled between "in favor" and "out of favor". It it is a real company with a CEO who is on side of investors as he is the biggest investor in it.